Introduction {#S0001}
============

Arterial stiffness reflects the degree of arteriosclerosis; it is considered to be a good predictor of cardiovascular events.[@CIT0001] It also is an index of vascular function in conjunction with cardiac function. Arterial stiffness is physically represented by an elastic modulus, but it is not easy to measure in blood vessels in vivo.[@CIT0002] Meanwhile, it has been shown that the elastic modulus of blood vessels is related to pulse wave velocity (PWV),[@CIT0003],[@CIT0004] and PWV has become widely used around the world as a surrogate marker of arterial stiffness since it is relatively easy to measure.[@CIT0001]

However, the drawback of PWV is its essential dependence on blood pressure at the measuring time.[@CIT0005],[@CIT0006] Since the measured value of PWV changes, it is difficult to determine whether it is due to changes in blood pressure or due to changes in the proper arterial stiffness. To overcome this disadvantage, attempts were made to devise a new index. Hayashi et al[@CIT0007] proposed the stiffness parameter β, which provides the proper arterial stiffness and it is not affected by the blood pressure at measuring time. Subsequently, Kawasaki et al[@CIT0008] reported a method of calculating β using an ultrasonic diagnostic apparatus, which has become widely used clinically. However, this stiffness parameter β was applied to only one part of the artery.

In 2004, the cardio--ankle vascular index (CAVI) was developed[@CIT0009] based upon the Kawasaki's β formula and the Bramwell-Hill equation. CAVI reflects the arterial stiffness of the arterial tree from the origin of the aorta to the ankle arteries. In this system, PWV is used. The independency of CAVI has been theoretically and experimentally verified. Throughout the world many researchers have applied this index in numerous studies; nearly 600 relevant papers have been published over the last 15 years, and the concept of CAVI has become widely accepted with many valuable findings documented.[@CIT0010]--[@CIT0012]

Recently, however, Spronck et al[@CIT0013]--[@CIT0015] proposed a variant index termed CAVI~0~ asserting that CAVI is dependent on blood pressure, whereas CAVI~0~ is not. Thus, a controversy was raised regarding the independency of CAVI and CAVI~0~ from blood pressure at the measuring time.[@CIT0016],[@CIT0017] Since that time, several papers reporting the comparison between CAVI and CAVI~0~ have been published, but the difference between the two indices is difficult to understand in most studies because they compared the indices using mathematical formulas and statistical analyses.

The purpose of this review is to describe the lesson learned from this controversy. We clarify the features of PWV used in the calculation of CAVI and verify CAVI with reference to CAVI~0~ based on the features of PWV. Further, we describe the validity of CAVI by showing actual clinical data provided in recent literature. In addition, the recent reports on the advantages and claimed disadvantages of CAVI are reviewed.

Blood Pressure Dependency in PWV {#S0002}
================================

Arterial stiffness can be presented by bulk modulus, which means how hard is it for the vessel to expand in diameter (D) against the change of pressure (P), and the relationship of PWV with bulk modulus is shown by the Bramwell-Hill equation ([[Supplement Seq.1](https://www.dovepress.com/get_supplementary_file.php?f=223330A.pdf)]{.ul}). If the bulk modulus is constant, PWV is also constant and not dependent on P. However, in the actual artery, the bulk modulus or PWV changes in accordance with P, which makes it difficult to measure the inherent arterial stiffness.

In order to overcome this problem, Hayashi et al[@CIT0007] found that P and D have an exponential relationship; they defined the β formula, which provides the index of inherent arterial stiffness independent of P ([[Supplement Seq.2](https://www.dovepress.com/get_supplementary_file.php?f=223330A.pdf)]{.ul}).

Combining the β formula and the Bramwell-Hill equation yields [Equation 1](#M0001). ([[Supplement Seq.3-8](https://www.dovepress.com/get_supplementary_file.php?f=223330A.pdf)]{.ul}) $$\documentclass[12pt]{minimal}
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\end{document}$$

\[β: specific stiffness of the blood vessel, *ρ*: blood density, PWV: pulse wave velocity, P: blood pressure, P~0~: reference blood pressure\]

This equation shows the relationship between PWV, P and β. It may look complex, but the essence is quite simple, since $\documentclass[12pt]{minimal}
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\end{document}$ is generally small, as will be shown later, and it can be regarded as negligible. Then, [Equation 1](#M0001) can be transformed into [Equation 2](#M0002) $$\documentclass[12pt]{minimal}
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As *ρ* can be considered as constant, Equation 2 means that PWV^2^ is approximately proportional to blood pressure P for the same β. This is the essential nature of the blood pressure dependency of PWV in the artery where diameter change has an exponential relationship with P. [Figure 1](#F0001){ref-type="fig"} shows the relationship between P and PWV calculated by [Equation 1](#M0001). Obviously, PWV is almost proportional to the square root of blood pressure P for the same β.Figure 1Relationship between P and PWV in Equation 1.**Abbreviations:** P, blood pressure; PWV, pulse wave velocity; β, specific stiffness of the blood vessel.

In other words, since PWV^2^ is almost proportional to P, proper arterial stiffness which is independent of blood pressure can be obtained by dividing PWV^2^ by P as a proportional coefficient.

PWV Change in Cardiac Cycle {#S0003}
===========================

As stated above, PWV^2^ is approximately proportional to P for the same β, and as such, PWV changes in accordance with the blood pressure between diastolic pressure (Pd) and systolic pressure (Ps) during the cardiac cycle. It is already known that PWV at systolic pressure (PWVs) is larger than that at diastolic pressure (PWVd) as shown in [Figure 2](#F0002){ref-type="fig"}. In the past, PWV could only be measured on a foot-to-foot basis in the pulse wave, which corresponds to the diastolic phase. Recently, with the progress of measuring technologies, such as high speed and high-resolution ultrasound imaging or MRI, it has become possible to measure PWV at various points in the cardiac cycle. Many papers have already reported that PWV in the systolic phase has a greater clinical significance than in the diastolic phase. Mirault et al[@CIT0018] revealed changes in PWV during the cardiac cycle using an ultrafast ultrasound imaging system in healthy volunteers (n=102) and in vascular Ehlers-Danlos syndrome (vEDS) patients (n=37). vEDS is a rare vascular disease resulting in mutations in the collagen type III gene. PWV at early-systole (PWVearly) and end-systole (PWVend) were 5.6±1.2m/s and 7.3±2.0m/s, respectively, in healthy subjects, and 6.0±1.5m/s and 6.7±1.5m/s, respectively, in vEDS patients.[@CIT0018] The results clearly indicate that PWV at the systolic phase is much larger than that at the diastolic phase. The lower increase of PWV in vEDS patients was attributed to the lack of stiffening due to the abnormal collagen in the arterial wall.Figure 2Schematics of the PWV in the cardiac cycle.**Abbreviations:** P, blood pressure; PWV, pulse wave velocity; PWVs, PWV at systolic blood pressure; PWVd, PWV at diastolic blood pressure.

Hermeling et al[@CIT0019] also reported the differences of PWV in the cardiac cycle and suggested a greater clinical significance of PWV at the systolic phase.

Corresponding Blood Pressure of PWV Used in CAVI Calculation {#S0004}
============================================================

As shown in [Figure 3](#F0003){ref-type="fig"}, VaSera system measures haPWV, which is the PWV from the heart to the ankle to obtain CAVI. In fact, haPWV was obtained by dividing the length of the arterial tree by the time of the pulse from the heart to the ankle. The trouble is the difficulty to identify the accurate time for the pulse to start at the origin of the aorta. Thus, the VaSera system uses a slightly complex contrivance. The pulse propagation time from heart to ankle is divided into two time periods, one is the time from heart to brachium (hbTime), and the other is the time difference between the brachium and ankle (baTime). The hbTime is measured as the time from heart sound II to the dicrotic notch of the pulse at the brachium. Since hbTime is measured at the blood pressure level of the dicrotic notch, the heart to brachium PWV (hbPWV) corresponds to the PWVend in the cardiac cycle. On the other hand, since baTime is measured at the foot level of the pulse waves, the brachial-ankle PWV (baPWV) corresponds to PWVearly. As a result, haPWV is the PWVm, which is the PWV at the mid pressure (Pm) between Pd and Ps. Although the blood pressure level at end-systole phase depends on the case and Pm may fluctuate, it is not a big error to evaluate it as Pm = (Ps + Pd)/2. The important fact here is that the corresponding blood pressure of haPWV in CAVI is not Pd, but rather Pm.Figure 3Schematics of the PWV from heart to ankle measured by cardio-ankle vascular index.**Abbreviations:** PWV, pulse wave velocity; hbPWV, heart to brachium PWV; baPWV, brachium to ankle PWV; haPWV, heart to ankle PWV; PWVend, PWV at end-systole phase; PWVearly, PWV at early-systole phase.

Conceptual Meaning of the CAVI {#S0005}
==============================

Now, we look over the formula again simply to clarify the meaning of CAVI.

CAVI equation is shown as [Equation 3](#M0003). $$\documentclass[12pt]{minimal}
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\[PWV: pulse wave velocity of the arterial tree from the origin of the aorta to the ankle, Ps: systolic blood pressure, Pd: diastolic blood pressure, *ρ*: blood density, $\documentclass[12pt]{minimal}
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\end{document}$: Ps--Pd, a, b: coefficients[@CIT0020]\].

The essence of CAVI is inside the parentheses of [Equation 3](#M0003), and we define it as CAVI' in Equation 4, which is the value without coefficients[@CIT0020] "a" and "b" $$\documentclass[12pt]{minimal}
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\end{document}$, a blood pressure term is mathematically proven[@CIT0017] to be approximated by $\documentclass[12pt]{minimal}
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In this article, we refrain from mathematical expressions as much as possible and show them schematically. The blood pressure term $\documentclass[12pt]{minimal}
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\end{document}$ is the average rate of change in natural logarithm blood pressure ln(P) when the blood pressure P changes from Pd to Ps. This term is shown as an incline of the line which cuts the curve of ln(P) at Pd and Ps ([Figure 4](#F0004){ref-type="fig"}); obviously, this incline closely resembles that in a tangent of ln(P) at Pm. Basically, the incline of the tangent is the differential value of the curve. Due to the interesting nature of logarithm's differentiation, the differential value of ln(P) is 1/P, and the incline of the tangent at Pm is 1/Pm. Thus, [Equation 5](#M0005), which represents the important attribute of CAVI, is introduced. $$\documentclass[12pt]{minimal}
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\end{document}$$Figure 4Schematics to show $\documentclass[12pt]{minimal}
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$${{\ln \left({{\rm{Ps}}} \right) - \ln \left({{\rm{Pd}}} \right)} \over {{\rm{Ps}} - {\rm{Pd}}}} \approx {1 \over {{\rm{Pm}}}}$$
\end{document}$.**Abbreviations:** P, blood pressure; Ps, systolic blood pressure; Pd, diastolic blood pressure; Pm, mid-pressure.

As stated in the clause of blood pressure dependency of PWV, PWV^2^ is approximately proportional to blood pressure P. In CAVI, also as stated, PWV corresponds to Pm, and by dividing PWV^2^ with Pm, an inherent arterial stiffness which is independent of blood pressure can be obtained. We have reported in a large population study that haPWV in CAVI is mostly correlated with Pm.[@CIT0017] This is the essential meaning of CAVI.

Verification with Clinical Data {#S0006}
===============================

Now, we verify the validity of CAVI with the actual clinical data. We presented the comparison results between CAVI and CAVI~0~ based on the medical examination data of a large population.[@CIT0021] By reviewing the data of the paper, we verified each element of CAVI. The studied populations are in two groups: a healthy group (n=5,293; 3,071 women and 2,222 men) and a hypertensive group (n=3,338; 1,006 women and 2,332 men).
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---------------------------------------------------
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\end{document}$, the reciprocal of the blood pressure term of CAVI, was previously presented in a publication.[@CIT0017] Here, we show the separate results for the healthy group and the hypertensive group. As shown in [Figure 5A](#F0005){ref-type="fig"} and [B](#F0005){ref-type="fig"}, the coefficients of correlation were r=0.997 (p\<0.001) for both groups, indicating that the blood pressure term of CAVI is almost equal to $\documentclass[12pt]{minimal}
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\end{document}$.Figure 5Relationship between $\documentclass[12pt]{minimal}
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\end{document}$ and Pm for healthy group (**A**) and hypertensive group (**B**) analyzed with the data from Shirai et al.[@CIT0021] Relationship between CAVIref and $\documentclass[12pt]{minimal}
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\end{document}$ for healthy group (**C**) and hypertensive group (**D**) analyzed with the data from Shirai et al.[@CIT0021]**Abbreviations:** Ps, systolic blood pressure; Pd, diastolic blood pressure; Pm, mid-pressure; CAVIref, cardio-ankle vascular index (CAVI) with reference blood pressure; P~0~, reference blood pressure.

Influence of Reference Blood Pressure Term $\documentclass[12pt]{minimal}
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\end{document}$ {#S0006-S2002}
-------------------------------------------------------------------------

The basic equation [Equation 1](#M0001) has a reference blood pressure term of $\documentclass[12pt]{minimal}
\usepackage{wasysym}
\usepackage[substack]{amsmath}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage[mathscr]{eucal}
\usepackage{mathrsfs}
\DeclareFontFamily{T1}{linotext}{}
\DeclareFontShape{T1}{linotext}{m}{n} {linotext }{}
\DeclareSymbolFont{linotext}{T1}{linotext}{m}{n}
\DeclareSymbolFontAlphabet{\mathLINOTEXT}{linotext}
\begin{document}
$${\rm{ln}}\left({{{\rm{P}} \over {{{\rm{P}}_0}}}} \right)$$
\end{document}$, but CAVI does not have this term. Therefore, in order to assess the effect of the presence or absence of the term, an equation including a reference blood pressure term in which P=Pm is substituted into [Equation 1](#M0001) is defined as CAVI~ref~ in [Equation 6](#M0006). $$\documentclass[12pt]{minimal}
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\end{document}$$

When the values with and without $\documentclass[12pt]{minimal}
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\end{document}$ are compared in [Equation 6](#M0006), the influence of the reference blood pressure term is evaluated, as shown in [Figure 5C](#F0005){ref-type="fig"} and [D](#F0005){ref-type="fig"}. The coefficients of correlation were r=0.997 and r=0.998 (p\<0.001for both) for the healthy group and hypertensive group, respectively, indicating that the influence of the reference blood pressure term is small and negligible.[@CIT0021]

Comprehensive Comparison of the Values {#S0007}
======================================

Now, we compare the data comprehensively. Here, CAVI~0~ formula[@CIT0013] is described in [Equation 7](#M0007). $$\documentclass[12pt]{minimal}
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This equation is obtained by substituting P = Pd in [Equation 1](#M0001), and the reason for the substitution is based on the assumption that PWV in CAVI is the PWV at Pd, which causes markedly irrational results.

First, the relationship between Pm and CAVI~ref~ is compared with the relationship between Pd and CAVI~0~. The purpose of this comparison is to confirm which blood pressure, Pm or Pd, is appropriate to divide the same PWV^2^ to obtain the blood pressure-independent inherent arterial stiffness. The results are shown with mean values and standard deviation data plotted in every 2 mmHg group ([Figure 6](#F0006){ref-type="fig"}). In both healthy and hypertensive groups, CAVI~ref~ has a slightly positive relationship with Pm, and it is acceptable because it is considered to have an increase in arterial stiffness due to long-term exposure to blood pressure. On the contrary, CAVI~0~ has a negative relationship with Pd, and this is obviously strange.Figure 6Relationship of the mean values of CAVIref and CAVI~0~ with Pm and Pd in every 2 mmHg groups for healthy and hypertensive groups analyzed with the data from Shirai et al.[@CIT0021]**Abbreviations:** CAVIref, cardio-ankle vascular index (CAVI) with reference blood pressure; CAVI~0~, a variant index of cardio-ankle vascular index; Pm, mid-pressure; Pd, diastolic blood pressure.

Furthermore, it was reported[@CIT0021] that CAVI~0~ values in hypertensive women aged 30--39 years are significantly less than the values of healthy women. The reason for these questionable results is the mismatching of the calculation in that PWV^2^ is divided by Pd instead of Pm.

Next, CAVI~0~ and CAVI', without coefficients of "a" and "b", are compared with CAVI~ref~, thought to be the theoretical value of inherent arterial stiffness, as shown in [Figure 7](#F0007){ref-type="fig"}. CAVI' is approximately equal to CAVI~ref~, but CAVI~0~ shows clearly over-estimated values in both healthy and hypertensive groups. This is the essence of the discrepancy between CAVI and CAVI~0~ found in recent publications.Figure 7Relationship of CAVI' and CAVI~0~ with CAVIref for healthy and hypertensive groups analyzed with the data from Shirai et al.[@CIT0021]**Abbreviations:** CAVI', cardio-ankle vascular index (CAVI) without the coefficients "a" and "b"; CAVI~0~, a variant index of cardio-ankle vascular index; CAVIref, CAVI with reference blood pressure.

Recent Pro and Con Articles on CAVI {#S0008}
===================================

First, we review an article critical of CAVI. Ato[@CIT0022] published a paper stating that CAVI is problematic. This allegation is based on misunderstandings about CAVI, and therefore, we were obliged to resolve those misunderstandings here.

The paper of Ato[@CIT0022] argues that the coefficients "a" and "b" of CAVI, defined in the previous study,[@CIT0020] are inappropriate because they underestimate values in the high range. However, this point has been already discussed in our previous paper,[@CIT0020] and it has been proven that the presence or absence of the coefficient does not change the clinical significance. The coefficients were set for the purpose of matching with the Hasegawa PWV scale, which already had vast clinical data, at the time of the development of CAVI, and clinical effectivity has been widely been demonstrated. However, since the coefficient values were disclosed in our previous paper,[@CIT0020] it has also recently become possible to study with values that do not include coefficients. The data can simply be converted by a tool ([[Supplementary digital content 1](https://www.dovepress.com/get_supplementary_file.php?f=223330.pdf)]{.ul}). In the conversion tool, the CAVI values without the coefficients "a" and "b" are expressed as "CAVIβ", which is described as CAVI' in this article.

The next point is the assertion that CAVI depends on blood pressure, citing papers[@CIT0023] in which CAVI is changed in autonomic nerve stimulation tests such as the Cold pressor test (CPT) and Hand grip test (HGT). However, the fact is that with stimulated sympathetic nerves by CPT or HGT, the stiffness of blood vessels including smooth muscles increases, along with the change of blood pressure. This mechanism has been explained by numerous articles.[@CIT0024]--[@CIT0026] CAVI correctly showed the increase of stiffness, and this result does not mean that CAVI is blood pressure dependent at the measuring time.

Since this point is often confused, the meaning of blood pressure independency is clarified here. Arterial stiffness is basically divided into the inherent stiffness and blood pressure-dependent change, as shown in [Figure 8](#F0008){ref-type="fig"}. The inherent stiffness includes physiological and functional elements as well as organic and structural elements. The former elements can change acutely, while the latter changes over the long term. Among them, CAVI only eliminates the blood pressure-dependent change, and it represents the inherent arterial stiffness including both organic and structural, and physiological and functional elements. Therefore, changes in physiological and functional stiffness, which are caused by CPT or such autonomic nerve stimulation, are reflected correctly. This is the true value and the meaning of blood pressure independency.Figure 8Schematics of the meaning in blood pressure independency of the arterial stiffness.**Abbreviation:** CAVI, cardio-ankle vascular index.

With some more unreasonable claims, not even worthy of discussion, the paper[@CIT0022] as a whole is questionable based on misunderstandings.

Next, we introduce one of the most recent publications showing the usefulness of CAVI. Kirigaya et al[@CIT0027] published an excellent article investigating the impact of arterial stiffness assessed with CAVI on the long-term outcome after acute coronary syndrome (ACS). A total of 387 consecutive patients with ACS were enrolled and CAVI and baPWV were measured. The patients were divided into two groups of low-CAVI (\<8.35) and high-CAVI.

As a result, Kaplan-Meier analysis demonstrated a significantly higher probability of adverse cardiovascular events (MACE) in the high-CAVI group, and multivariate analysis suggested that CAVI was an independent predictor of MACE, but baPWV was not.

Also, the incremental predictive value of adding CAVI to GRACE score (GRS) was investigated, and stratified by CAVI and GRS, a significantly higher rate of MACE was found in patients with both higher CAVI and higher GRS than the other groups. Further, the addition of CAVI to GRS enhanced net reclassification improvement and integrated discrimination improvement.

The impact of this paper of Kirigaya et al[@CIT0027] is that it has shown that arterial stiffness, determined using CAVI, was an independent long-term predictor of MACE in patients with ACS, and that CAVI can improve the risk stratification based on GRS. Blood pressure is important for prognosis prediction, and it is thought that baPWV, which contains a marked blood pressure factor, has higher prognostic prediction ability, but in reality, it is not significant in baPWV, and CAVI is significant. This result has doubtlessly great significance in the future research on arterial stiffness.

Limitations and Perspective {#S0009}
===========================

Both in CAVI and CAVI~0~, peripheral vessels are included in the measurements. When the subjects have peripheral arterial diseases such as atherosclerosis obliterans, the measurements will be unreliable. Also, it has been claimed that evaluating a longer arterial length should add important additional information to the measurements, but it could be interpreted also as confounding factors.[@CIT0028] These are the limitations in the measurements of both CAVI and CAVI~0~.

However, in this association, it was reported that the response of arteries to the vasodilating agents such as nitroglycerin is different between central and peripheral,[@CIT0029] suggesting that the meaning and role of arterial stiffness differ depending on the segments. As a perspective, more useful information would be obtained in the future if blood pressure-independent arterial stiffness for both central and peripheral segments could be measured separately and more easily.

Conclusion {#S0010}
==========

The conceptual meaning of CAVI is reconfirmed and verified to be as follows: Arterial stiffness is represented by the bulk modulus of the blood vessel, which is approximately proportional to blood pressure P. When it is divided by P, a proportionality constant is obtained, representing arterial stiffness independent of blood pressure.

CAVI and CAVI~0~ are compared with recent findings, and the claim that CAVI~0~ is less blood pressure dependent than CAVI has been shown to be suspicious, although the proposition of CAVI~0~ has contributed to deeper discussions on the blood pressure independency of CAVI. As a summary, common and different points between CAVI and CAVI~0~ are shown in [Table 1](#T0001){ref-type="table"}.Table 1Common and Different Points Between CAVI and CAVI~0~**Common Points** Measured arteryArterial tree from the origin of the aorta to the ankle at tibial artery Measured arteryArterial tree from the origin of the aorta to the ankle at tibial artery Used valuesBP at upper brachial arteryPWV of the total measured artery Propagation time obtained for PWVhbTime + baTime**Different Points**CAVICAVI~0~ Formula$\documentclass[12pt]{minimal}
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We conclude that CAVI~0~ is questionable because of the mismatching in the formula and CAVI is a reliable and sensitive index of blood pressure-independent arterial stiffness, in both organic and functional components.
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[^1]: **Abbreviations:** CAVI, cardio-ankle vascular index; BP, blood pressure; PWV: pulse wave velocity; hbTime, pulse wave propagation time from heart to brachium; baTime, time difference between the pulses at brachium and ankle; Ps, systolic blood pressure; Pd, diastolic blood pressure; P~0~, reference blood pressure; *ρ*, blood density; ΔP, Ps--Pd; a and b, coefficients; β, specific stiffness of the blood vessel; Pm, mid-pressure.
